Cat Cancer Genetics Mirror Human Tumors and Could Unlock New Treatments

Cancer research has long relied on laboratory animal models, but a compelling new study suggests that our household cats may be among the most valuable allies in the fight against human cancer. Researchers from the University of Guelph led an international team that genetically analyzed tumors from nearly 500 domestic cats, representing the largest study of feline cancer genetics ever conducted. The findings, published in the journal Science, reveal deep molecular similarities between cat and human cancers that could reshape how scientists approach tumor biology and treatment development.

The study screened cat tumors for mutations in cancer driver genes — genes that, when altered, cause cells to proliferate uncontrollably. The team found that many of the same driver genes implicated in human cancers are also mutated in feline tumors. The clearest parallel emerged in mammary cancer: more than half of aggressive cat breast tumors carried mutations in FBXW7, a gene that regulates proteins controlling cell growth. In human breast cancer, FBXW7 mutations are associated with poorer prognosis, making this a potentially shared therapeutic target.

Similarities extended across multiple cancer types, including blood, bone, lung, skin, gastrointestinal, and central nervous system tumors. This breadth suggests that feline cancer biology is not an isolated curiosity but a genuinely informative parallel to human oncology.

One particularly compelling angle is the shared environment. Unlike lab mice, cats live alongside humans — breathing the same indoor air, encountering the same household chemicals, and facing similar lifestyle-related exposures. This makes spontaneously occurring feline cancer a naturalistic model for studying how environmental factors interact with genetic vulnerability to promote tumor development.

The researchers have made their genetic dataset freely available to the scientific community, creating an open resource for future drug discovery and cross-species cancer research. While direct clinical applications remain years away, the convergence of cat and human tumor genetics adds meaningful momentum to precision oncology efforts and opens new investigative avenues for understanding — and eventually preventing — some of the most deadly cancers in both species.